Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−9.59 MXN
−10.24 B MXN
151.47 B MXN
290.43 M
About BAUSCH HEALTH COMPANIES INC
Sector
CEO
Thomas J. Appio
Headquarters
Laval
Website
Founded
1994
FIGI
BBG0077HC5W9
Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
BHC4928364
Bausch Health Companies Inc. 5.25% 30-JAN-2030Yield to maturity
25.33%
Maturity date
Jan 30, 2030
BHC4986567
Bausch Health Companies Inc. 6.25% 15-FEB-2029Yield to maturity
24.75%
Maturity date
Feb 15, 2029
BHC4832634
Bausch Health Companies Inc. 7.0% 15-JAN-2028Yield to maturity
23.24%
Maturity date
Jan 15, 2028
BHC5081958
Bausch Health Companies Inc. 5.25% 15-FEB-2031Yield to maturity
22.68%
Maturity date
Feb 15, 2031
BHC4832637
Bausch Health Companies Inc. 7.25% 30-MAY-2029Yield to maturity
22.55%
Maturity date
May 30, 2029
BHC4927761
Bausch Health Companies Inc. 5.0% 30-JAN-2028Yield to maturity
22.36%
Maturity date
Jan 30, 2028
BHC5082241
Bausch Health Companies Inc. 5.0% 15-FEB-2029Yield to maturity
21.53%
Maturity date
Feb 15, 2029
BHC4634780
Bausch Health Companies Inc. 8.5% 31-JAN-2027Yield to maturity
17.13%
Maturity date
Jan 31, 2027
Explore more bonds
Frequently Asked Questions
The current price of BHC/N is 152.50 MXN — it has decreased by −23.82% in the past 24 hours. Watch BAUSCH HEALTH COMPANIES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BAUSCH HEALTH COMPANIES INC stocks are traded under the ticker BHC/N.
BHC/N stock has fallen by −23.82% compared to the previous week, the month change is a −23.82% fall, over the last year BAUSCH HEALTH COMPANIES INC has showed a −1.61% decrease.
We've gathered analysts' opinions on BAUSCH HEALTH COMPANIES INC future price: according to them, BHC/N price has a max estimate of 243.24 MXN and a min estimate of 60.35 MXN. Watch BHC/N chart and read a more detailed BAUSCH HEALTH COMPANIES INC stock forecast: see what analysts think of BAUSCH HEALTH COMPANIES INC and suggest that you do with its stocks.
BHC/N reached its all-time high on Mar 9, 2021 with the price of 730.00 MXN, and its all-time low was 90.80 MXN and was reached on Jul 29, 2022. View more price dynamics on BHC/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BHC/N stock is 31.27% volatile and has beta coefficient of 0.66. Track BAUSCH HEALTH COMPANIES INC stock price on the chart and check out the list of the most volatile stocks — is BAUSCH HEALTH COMPANIES INC there?
Today BAUSCH HEALTH COMPANIES INC has the market capitalization of 58.00 B, it has increased by 3.86% over the last week.
Yes, you can track BAUSCH HEALTH COMPANIES INC financials in yearly and quarterly reports right on TradingView.
BAUSCH HEALTH COMPANIES INC is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BHC/N earnings for the last quarter are 23.18 MXN per share, whereas the estimation was 20.63 MXN resulting in a 12.36% surprise. The estimated earnings for the next quarter are 22.24 MXN per share. See more details about BAUSCH HEALTH COMPANIES INC earnings.
BAUSCH HEALTH COMPANIES INC revenue for the last quarter amounts to 50.95 B MXN, despite the estimated figure of 48.77 B MXN. In the next quarter, revenue is expected to reach 49.87 B MXN.
BHC/N net income for the last quarter is −1.69 B MXN, while the quarter before that showed 183.38 M MXN of net income which accounts for −1.02 K% change. Track more BAUSCH HEALTH COMPANIES INC financial stats to get the full picture.
No, BHC/N doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 16, 2024, the company has 20.27 K employees. See our rating of the largest employees — is BAUSCH HEALTH COMPANIES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAUSCH HEALTH COMPANIES INC EBITDA is 60.58 B MXN, and current EBITDA margin is 32.71%. See more stats in BAUSCH HEALTH COMPANIES INC financial statements.
Like other stocks, BHC/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAUSCH HEALTH COMPANIES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAUSCH HEALTH COMPANIES INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAUSCH HEALTH COMPANIES INC stock shows the sell signal. See more of BAUSCH HEALTH COMPANIES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.